Systematic identification of functionally relevant risk alleles to stratify aggressive versus indolent prostate cancer.

about

Systematic identification of functionally relevant risk alleles to stratify aggressive versus indolent prostate cancer.

Item

http://www.wikidata.org/entity/Q52645860

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

Systematic identification of f ...... rsus indolent prostate cancer.

@en

Systematic identification of f ...... rsus indolent prostate cancer.

@nl

type

Item

label

Systematic identification of f ...... rsus indolent prostate cancer.

@en

Systematic identification of f ...... rsus indolent prostate cancer.

@nl

prefLabel

Systematic identification of f ...... rsus indolent prostate cancer.

@en

Systematic identification of f ...... rsus indolent prostate cancer.

@nl

P1476

Systematic identification of f ...... rsus indolent prostate cancer.

@en

P2093

Ayesha Mirchandani

http://www.w3.org/2001/XMLSchema#string

Mark Emberton

http://www.w3.org/2001/XMLSchema#string

Massimo Loda

http://www.w3.org/2001/XMLSchema#string

Mieke Van Hemelrijck

http://www.w3.org/2001/XMLSchema#string

Salpie Nowinski

http://www.w3.org/2001/XMLSchema#string

P2860

The rs10993994 risk allele for prostate cancer results in clinically relevant changes in microseminoprotein-beta expression in tissue and urine

An oncogene-tumor suppressor cascade drives metastatic prostate cancer by coordinately activating Ras and nuclear factor-kappaB

Incorporation of tissue-based genomic biomarkers into localized prostate cancer clinics

Role of multiparametric magnetic resonance imaging in early detection of prostate cancer

FISH analysis of 107 prostate cancers shows that PTEN genomic deletion is associated with poor clinical outcome.

Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement

A genome-wide search for loci interacting with known prostate cancer risk-associated genetic variants

Prostate cancer screening in men aged 50–69 years (STHLM3): a prospective population-based diagnostic study

Genome-wide association study identifies a genetic variant associated with risk for more aggressive prostate cancer.

Recurrent copy number alterations in prostate cancer: an in silico meta-analysis of publicly available genomic data.

P304

12812-12824

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.18632/ONCOTARGET.24400

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Ben O'Leary

Anita Grigoriadis

Aida Santaolalla

P577

2018-02-05T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29560112

http://www.w3.org/2001/XMLSchema#string

P932

5849176

http://www.w3.org/2001/XMLSchema#string